Skip to main content
Clinical Trials/NCT01527617
NCT01527617
Completed
Not Applicable

The Effect of Chronic Consumption of a Cranberry Beverage on Inflammation and Oxidative Stress in Healthy But Overweight/Obese Subjects: A Randomized Clinical Trial

Tufts University2 sites in 1 country79 target enrollmentFebruary 2012
ConditionsInflammation

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Inflammation
Sponsor
Tufts University
Enrollment
79
Locations
2
Primary Endpoint
Change in biomarkers of oxidative stress compared with placebo.
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The objective of this randomized, double-blind, placebo-controlled, parallel-design clinical trial is to investigate the potential antioxidant benefits of a cranberry beverage. The investigators hypothesize the chronic consumption of this beverage will improve indices of oxidative stress, inflammation, endothelial function, and glucoregulation. The investigators also hypothesize that these benefits will be particularly evident following an oral glucose tolerance test.

Registry
clinicaltrials.gov
Start Date
February 2012
End Date
February 2013
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Men \& women, aged 30-70 years
  • BMI 27-34.9 kg/m2
  • waist:hip ratio \> 0.8 for women and \> 0.9 for men

Exclusion Criteria

  • Cigarette smoking and/or nicotine replacement use within last 6 months
  • Individuals taking estrogen or testosterone
  • Use of cholesterol-lowering medications
  • Use of blood pressure-lowering medications
  • Regular use (\> 1x/wk) of any stomach acid-lowering medications or laxatives (including fiber supplements)
  • Cardiovascular (heart) disease
  • Gastrointestinal disease
  • Kidney disease
  • Endocrine disease: including diabetes, untreated thyroid disease
  • Rheumatoid arthritis

Outcomes

Primary Outcomes

Change in biomarkers of oxidative stress compared with placebo.

Time Frame: Baseline and 8 weeks

Change in biomarkers of inflammation compared with placebo

Time Frame: Baseline and 8 weeks

Study Sites (2)

Loading locations...

Similar Trials